Carl-Henrik heroine

from Wikipedia, the free encyclopedia

Carl-Henrik Heldin (born August 9, 1952 in Växjö ) is a Swedish molecular biologist and cancer researcher . He has been with Uppsala University since 1980 and mainly deals with the effects of growth factors such as PDGF and TGF-β . At the same time, he is director of the Ludwig Institute for Cancer Research in Uppsala and, since 2013, chairman of the Nobel Foundation .

Career

Carl-Henrik Heldin studied medicine at Uppsala University from 1971 to 1975 . At the same time, he began studying for a Bachelor of Science there in 1972 . With the end of his medical studies, he then worked on his doctoral thesis at the Institute for Medical and Physiological Chemistry at Uppsala University, where he dealt with growth factors for human cell cultures . He defended the work in 1980 and received his Ph.D. before completing his Bachelor of Science a year later.

Immediately after completing his doctorate, Heldin was taken on as a research assistant in Uppsala and received a scholarship from the Swedish Cancer Society in 1981 , which hired him as a scientist in 1984. Two years later he was appointed the new head of the Uppsala branch of the globally active Ludwig Institute for Cancer Research , before being offered a professorship in molecular cell biology at Uppsala University in 1992 . Heldin has held both positions to this day.

In addition, Heldin was Vice President of the European Research Council from 2011 to 2013 , before he was elected as the new chairman of the Nobel Foundation in April 2013 .

Scientific work

In the area of cancer research, Heldin deals with growth factors , in particular with their signal transduction and their role in physiology and pathology . His work focuses primarily on the platelet-derived growth factor , transforming growth factor β and the family of SMAD proteins .

The Swede also acted as editor-in-chief of the journal Cancer Research from 2003 to 2009 . He himself has published over 600 specialist articles so far.

Honors

In addition to a number of other individual awards, Heldin was awarded the gold medal of the European Molecular Biology Organization (EMBO) in 1992 and the Meyenburg Prize in 1999 . He is also a member of numerous professional and scholarly societies , including EMBO (1989), the Royal Swedish Academy of Sciences (1991), the Royal Society of Sciences in Uppsala (1995), the Academia Europaea (1999) and the Norwegian Academy of Sciences (2009). In 2016 he was elected as an honorary foreign member of the American Academy of Arts and Sciences . He also received honorary doctorates from the Universities of Patras (2009), Helsinki (2010), Turku (2011) and Heidelberg (2011).

Personal

Heldin is married and has two children.

Web links

Individual evidence

  1. ^ Ludwig Uppsala Director Carl-Henrik Heldin new chairman of the Nobel Foundation. ludwigcancerresearch.org, April 11, 2013, accessed September 9, 2016 .
personal data
SURNAME Heroine, Carl-Henrik
ALTERNATIVE NAMES Heroine, Carl Henrik
BRIEF DESCRIPTION Swedish molecular biologist and cancer researcher
DATE OF BIRTH August 9, 1952
PLACE OF BIRTH Vaxjo , Sweden